Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Assets Average (2017 - 2025)

Anaptysbio filings provide 9 years of Assets Average readings, the most recent being $358.7 million for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average fell 26.58% year-over-year to $358.7 million, compared with a TTM value of $358.7 million through Dec 2025, down 26.58%, and an annual FY2025 reading of $424.1 million, down 9.4% over the prior year.
  • Assets Average hit $358.7 million in Q4 2025 for Anaptysbio, up from $344.2 million in the prior quarter.
  • The five-year high for Assets Average was $634.1 million in Q1 2022, with the low at $344.2 million in Q3 2025.
  • Median Assets Average over the past 5 years was $465.1 million (2023), compared with a mean of $483.4 million.
  • The sharpest move saw Assets Average surged 56.0% in 2022, then fell 26.58% in 2025.
  • Year by year, Assets Average stood at $533.7 million in 2021, then rose by 15.13% to $614.4 million in 2022, then fell by 23.53% to $469.9 million in 2023, then rose by 3.99% to $488.6 million in 2024, then decreased by 26.58% to $358.7 million in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $358.7 million, $344.2 million, and $378.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.